Singapore

2021 Edition

Articles
APAC: Diagnostics in the Post-COVID Era

COVID-19 has pushed diagnostics to the forefront of healthcare conversations across the world. Here, three leading lights from the Asia-Pacific medtech industry weigh in on what the new diagnostics paradigm might look like as the pandemic recedes…

Singapore: A Myriad of Biotech Financing Strategies

Since 2000, when Singapore first positioned biomedical research as the fourth pillar of the country’s economy, government funding towards innovative life scien…

Read the Full Version
The Challenges of Regulatory Convergence in APAC Medtech

Regulatory harmonisation for medical devices between countries in Asia-Pacific has long been a challenging issue, predominantly due to the extreme variation in cultures, economic development, governmental models, and healthcare systems in the region…

Singapore: Finding the Right Pharma Talent Post-COVID

Singapore – despite its modest USD 1.22 billion domestic market – has long been one of Asia’s leading biopharmaceutical hubs and a magnet for top talent. Multitudes of biopharma and medtech multinationals, as well as domestic start-ups, have based re…

Building a Globally Competitive Innovation Ecosystem in Singapore

Singapore recently outlined its latest Research, Innovation and Enterprise (RIE) 2025 plan, with plans to invest some USD 20 billion over the next 5 years. Here, three key stakeholders from government, academia, and industry weigh in on what Singa…

CEO Profile
Company Spotlight
Marine Queniart-Stojanovic
Sanofi Thailand, Malaysia & Singapore

Industry veteran Marine Queniart-Stojanovic, a self-described “global citizen with a French passport,” currently serves as Sanofi’s GM for general medicines in Thailand, Malaysia…

Company Spotlight
Guardant Health AMEA
Liquid Biopsies & The Future of Cancer Diagnostics

In 2020, the FDA granted its first approval to a comprehensive liquid biopsy, potentially representing a paradigm shift towards using liquid biopsies upfront as an easier, safer…

Thanks for reading!

The Digital Version of the Healthcare & Life Sciences Review: Singapore is available and optimized for desktop browsers.

Visit our website with your computer or download the pdf report

Read the Full Version

2021. Healthcare & Life Sciences Review was produced by Pharmaboardroom.

Copyright: All rights reserved. No part of this publication maybe reproduced in any form or by any means, whether electronic, mechanical or otherwise including photocopying, recording or any information storage or retrieval system without prior written consent of PharmaBoardroom. While every attempt is made to ensure the accuracy of the information contained in this report, neither PharmaBoardroom nor the authors accept any liabilities for errors and omissions. Opinions expressed in this report are not necessarily those of the authors. All the images belongs to its respective authors.

Report Director: Julija Lukaityte
Report Assistant: Anoushka Dhivare
Senior Editor: Patrick Burton, Louis Haynes
Publisher: Diana Viola
Graphic Designer: Miriam León

PharmaBoardroom

Contact us

+44 20 7867 3717 info@pharmaboardroom.com

For media inquiries, please contact: media@pharmaboardroom.com

Address

PharmaBoardroom Limited Lynton House, 7-12, Tavistock Square, London, United Kingdom, WC1H 9LT

Subscribe